131 related articles for article (PubMed ID: 38125127)
1. Retracted: Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9878436. PubMed ID: 38125127
[TBL] [Abstract][Full Text] [Related]
2. Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-
Ma H; Duan X; Zhang R; Li H; Guo Y; Tian Y; Huang M; Chen G; Wang Z; Li L
Evid Based Complement Alternat Med; 2022; 2022():8661288. PubMed ID: 35873644
[TBL] [Abstract][Full Text] [Related]
3. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
4. Loureirin B alleviates cardiac fibrosis by suppressing Pin1/TGF-β1 signaling.
Cheng M; Yang Z; Li R; Wu G; Zhang C
Eur J Pharmacol; 2022 Mar; 918():174791. PubMed ID: 35093323
[TBL] [Abstract][Full Text] [Related]
5. Caffeine and rolipram affect Smad signalling and TGF-β1 stimulated CTGF and transgelin expression in lung epithelial cells.
Fehrholz M; Speer CP; Kunzmann S
PLoS One; 2014; 9(5):e97357. PubMed ID: 24828686
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1/Smad Signalling in Proliferative Glomerulonephritis Associated with Autoimmune Diseases.
Chalkia A; Gakiopoulou H; Theochari I; Foukas PG; Vassilopoulos D; Petras D
Mediterr J Rheumatol; 2022 Jun; 33(2):176-184. PubMed ID: 36128207
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
8. Loureirin B Alleviates Myocardial Ischemia/Reperfusion Injury via Inhibiting PAI-1/TGF-
Kong F; Zhao M
Evid Based Complement Alternat Med; 2022; 2022():9128210. PubMed ID: 35535157
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
Yang J; Zhang X; Li Y; Liu Y
J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
[TBL] [Abstract][Full Text] [Related]
10. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
Ai K; Zhu X; Kang Y; Li H; Zhang L
Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
[TBL] [Abstract][Full Text] [Related]
11. Lefty-1 inhibits renal epithelial-mesenchymal transition by antagonizing the TGF-β/Smad signaling pathway.
Zhang L; Liu X; Liang J; Wu J; Tan D; Hu W
J Mol Histol; 2020 Feb; 51(1):77-87. PubMed ID: 32065356
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor (TGF)-beta1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation in vitro: peroxisome proliferator-activated receptor gamma acts as a negative regulator of TGF-beta1.
Chang HJ; Lee JH; Hwang KJ; Kim MR; Chang KH; Park DW; Min CK
Fertil Steril; 2008 Oct; 90(4 Suppl):1357-65. PubMed ID: 18082740
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis.
Leonardi A; Di Stefano A; Motterle L; Zavan B; Abatangelo G; Brun P
Clin Exp Allergy; 2011 Jan; 41(1):52-60. PubMed ID: 20977504
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling.
Phanish MK; Wahab NA; Hendry BM; Dockrell ME
Nephron Exp Nephrol; 2005; 100(4):e156-65. PubMed ID: 15855807
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9842747. PubMed ID: 38125084
[TBL] [Abstract][Full Text] [Related]
16. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated TGF-beta1-induced Smad signalling occurs as a result of defects in multiple components of the TGF-beta signalling pathway in human head and neck carcinoma cell lines.
Pring M; Prime S; Parkinson EK; Paterson I
Int J Oncol; 2006 May; 28(5):1279-85. PubMed ID: 16596245
[TBL] [Abstract][Full Text] [Related]
19. High-temperature Requirement Protein A1 Regulates Odontoblastic Differentiation of Dental Pulp Cells via the Transforming Growth Factor Beta 1/Smad Signaling Pathway.
Li XY; Ban GF; Al-Shameri B; He X; Liang DZ; Chen WX
J Endod; 2018 May; 44(5):765-772. PubMed ID: 29580722
[TBL] [Abstract][Full Text] [Related]
20. Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives.
Haydont V; Mathé D; Bourgier C; Abdelali J; Aigueperse J; Bourhis J; Vozenin-Brotons MC
Radiother Oncol; 2005 Aug; 76(2):219-25. PubMed ID: 16046020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
